Single Urine Panel Benzodiazepine

Product information

Single Panel Drug Urine Rapid Test detects 1 substance with specific result for the substance analyzed.  This urine drug test detects: BZO300.

Advantages of Urine test

• Easy to collect
• No limit to sample volume
• Long detection window 

General information

The Single Panel Benzodiazepine Rapid Test (Urine) is a rapid chromatographic immunoassay for the detection of Oxazepam (main metabolite) in the urine at a threshold-limit concentration of 300ng/ml. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert.

Benzodiazepines are drugs frequently prescribed for the symptomatic treatment of anxiety and sleep disorders. They produce their effects through specific receptors involving a neurochemical called gamma aminobutyric acid (GABA). Due to their increased safety and efficacy, benzodiazepines have replaced barbiturates in the treatment of anxiety and insomnia.

In emergency situations, patients may present with symptoms such as drowsiness, confusion, slurred speech, or respiratory depression—signs of benzodiazepine intoxication or overdose. A rapid test enables healthcare professionals to quickly confirm the presence of benzodiazepines, leading to timely interventions such as airway management, administration of reversal agents like flumazenil, and supportive care. Early identification can prevent life-threatening complications, such as respiratory failure or coma.

Single Panel Drug Urine Rapid Test screening delivers accurate, quick results for presence of drugs detected in human urine. A rapid test for the simultaneous, qualitative detection of drug and drug metabolites in human urine. This is ideal for healthcare professionals including professionals at point of care sites. Last but not least, the Single Panel Drug Urine Rapid Tests economical and reliable, accurate testing for professional use.